WFDC2 and chronic kidney disease: In conclusion, we demonstrated that elevated levels of serum HE4 at the time of biopsy were associated with decreased kidney function, and that HE4 elevation levels obviously increased with advanced renal fibrosis stage in patients with CKD, suggesting that HE4 may serve as a valuable clinical biomarker for renal fibrosis of CKD.